Infections by Neisseria gonorrhoeae are increasingly common, are often caused by antibiotic-resistant strains, and can result in serious and lasting sequelae, prompting the reemergence of gonococcal disease as a leading global health concern. N. gonorrhoeae is a human-restricted pathogen that primarily colonizes urogenital mucosal surfaces. Disease progression varies greatly between the sexes: men usually present with symptomatic infection characterized by a painful purulent urethral discharge, while in women, the infection is often asymptomatic, with the most severe pathology occurring when the bacteria ascend from the lower genital tract into the uterus and fallopian tubes. Classical clinical studies demonstrated that clinically infectious strains uniformly express Opa adhesins; however, their specificities were unknown at the time. While in vitro studies have since identified CEACAM proteins as the primary target of Opa proteins, the gonococcal specificity for this human family of receptors has not been addressed in the context of natural infection. In this study, we characterize a collection of low-passage-number clinicalspecimen-derived N. gonorrhoeae isolates for Opa expression and assess their CEACAM-binding profiles. We report marked in vivo selection for expression of phase-variable Opa proteins that bind CEACAM1 and CEACAM5 but selection against expression of Opa variants that bind to the neutrophil-restricted decoy receptor CEACAM3. This is the first study showing phenotypic selection for distinct CEACAM-binding phenotypes in vivo, and it supports the opposing functions of CEACAMs that facilitate infection versus driving inflammation within the genital tract.
N eisseria gonorrhoeae has persisted in the human population despite all attempts to limit the spread of infection (1) . The alarming rise in antibiotic-resistant strains and increase in the global incidence of infection have put N. gonorrhoeae at the forefront of national and international public health agendas (2) . N. gonorrhoeae is a sexually transmitted pathogen that most commonly colonizes the urogenital mucosa, although it may also be found on nasopharyngeal, rectal, and ocular surfaces. Disease manifestations vary greatly between men and women. Infections in men are commonly characterized by acute urethritis with profuse purulent discharge. This pus largely consists of polymorphonuclear leukocytes (PMNs), potently phagocytic cells responsible for bacterial elimination but with the potential to damage the surrounding tissues in the process (3) . In women, N. gonorrhoeae colonizes the endocervix, where it also has the potential to cause painful inflammation and cervical discharge; however, most infections in women are asymptomatic (2) . If left untreated, the gonococci may ascend into the female upper genital tract to promote a pathogenic inflammatory response that can precipitate severe health issues, including pelvic inflammatory disease (PID), ectopic pregnancies, and infertility (3) .
N. gonorrhoeae is a human-restricted pathogen that has evolved sophisticated mechanisms to facilitate colonization and persistence within its host. Essential for these processes are specialized adhesins that allow N. gonorrhoeae attachment to receptors expressed exclusively on human mucosal tissues. The type IV pilus mediates the initial bacterial attachment to the host cell. By virtue of its ability to retract, the pilus overcomes mucosal flow and brings the bacterium into close proximity to the epithelial cell (4) to facilitate a more intimate association and/or cellular invasion (5) . Studies using male human volunteers indicate that the pilus is not required for initial infection, although it may contribute to disease manifestations (6) .
The colony opacity-associated (Opa) proteins were recognized by their effects on interbacterial aggregation and leukocyte association (7, 8) and were later shown to mediate a tight secondary association between N. gonorrhoeae and the epithelia (9) . Each gonococcal isolate possesses ϳ11 different opa genes, each encoding antigenically and phenotypically distinct variants that reversibly turn expression "off" and "on" at a rate estimated to be 10
Ϫ3
to 10 Ϫ4 /cell/generation (10, 11) . N. gonorrhoeae isolates from both naturally infected men and women are predominantly Opa ϩ , as are isolates obtained from men experimentally infected with transparent (Opa phase-varied off) colonies (12) (13) (14) . Most gonococcal Opa variants bind to one or more members of the human CEACAM family of receptors (15) (16) (17) (18) (19) (20) . CEACAM receptors are members of the immunoglobulin (Ig) superfamily, containing an Ig variable-region-like N-terminal domain followed by a varying number of Ig constant-region-like domains exposed at the cell surface (21, 22) . CEACAM1, CEACAM3, CEACAM5 (carcino-embryonic antigen [CEA] ), and CEACAM6 (but apparently not other CEACAMs) are each capable of mediating neisserial adherence to and engulfment by the various tissues on which they are differentially expressed (16-20, 23, 24) . Epithelial CEACAMs (CEACAM1, CEACAM5, and CEACAM6) are all presumed to facilitate bacterial colonization (25, 26) . In the female genital tract, squamous epithelia express CEACAM5, whereas CEACAM1 is expressed on columnar epithelia of the endocervix and uterus (27) , allowing each to be accessible for direct docking by the gonococci. Moreover, CEACAM1 is widely expressed on lymphocytes, and CEACAM1-induced signaling can influence immune cell activation (28) (29) (30) (31) (32) (33) (34) (35) , potentially providing a mechanism for immune evasion by N. gonorrhoeae. While no study to date has looked at CEACAM expression within the male urethra, a transgenic mouse line expressing human CEACAMs in a manner that closely reflects the spatiotemporal expression pattern in humans expresses CEACAM5 on the urethral mucosal surface (36) .
Despite an abundance of evidence for the importance of Opa-CEACAM interaction for N. gonorrhoeae infection in vitro, the contribution of this association is challenging to assess in vivo. Most characterized gonococcal isolates bind to human CEACAM1 (15) , but their ability to bind other CEACAMs remains uncertain. Due to the host specificity of Neisseria, mouse models remain limited. However, expression of human CEACAM1 in a mouse allowed persistent colonization by N. meningitidis (37) , and a mouse model expressing human CEACAM5 showed increased gonococcal recovery from the lower genital tract (38) . In contrast, Opa binding to neutrophil CEACAM3 drives inflammation and gonococcal clearance (39) (40) (41) (42) (43) (44) (45) (46) (47) . The specific contribution of Opa binding to individual CEACAMs for N. gonorrhoeae colonization and pathogenesis in humans and how differences in CEACAM distribution between the sexes might affect the outcome of infection have not been addressed.
In this study, we sought to characterize gonococcal CEACAMbinding phenotypes expressed within the human urogenital tract. To this end, we obtained a collection of primary low-passagenumber clinical isolates (LPCIs) of N. gonorrhoeae from male urethral swabs or endocervical specimens taken from a sexually transmitted disease (STD) clinic (48) . Since binding specificity cannot be predicted by the antigenically hypervariable Opa protein sequences, we developed a high-throughput binding assay with transfected cells expressing individual human CEACAMs to define the specificity of each colony phenotype apparent within each low-passage-number clinical specimen. We observed clear selection for expression of Opa variants that bind to epithelial and leukocyte-expressed CEACAMs with concomitant selection against a CEACAM3-binding phenotype. Consistent with the detrimental effects of CEACAM3-dependent binding by neutrophils, a phase variant that binds to CEACAMs was actively phagocytosed, activated production of reactive oxygen species, promoted degranulation, and activated the release of proinflammatory cytokines from neutrophils, while its Opa-deficient variant did not. Together, these findings support a model in which Opa protein phase variation allows in vivo selection for neisserial phenotypes that facilitate persistence within the mucosal tissues.
MATERIALS AND METHODS
Reagents. Lipofectamine and hygromycin B were obtained from Invitrogen (Burlington, Ontario, Canada). Heparin sodium salt, ␤-mercaptoethanol (BME), paraformaldhyde (PFA), gelatin, and p-nitrophenyl phosphate (pNPP) were obtained from Sigma (Oakville, Ontario, Canada). Fraction V bovine serum albumin (BSA), 5-bromo-4-chloro-3-indolyl phosphate disodium salt (BCIP), nitrotetrazolium blue chloride (NBT), and G418 sulfate were obtained from Bioshop (Burlington, Ontario, Canada). Monoclonal antibody 4B12/C11, which recognizes all the gonococcal Opa variants described, was generously provided by M. Achtman (Max-Planck-Institut für Infektionsbiologie) (49) . The monoclonal antibody against the gonococcal pilus was a kind gift from M. So (Oregon Health Sciences University) (50) . The anti-gonococcal polyclonal antibody UTR01 was generated by three subcutaneous immunizations with killed N. gonorrhoeae N302 (Opa Ϫ ) as previously described (41) . Alkaline phosphatase (AP)-conjugated goat anti-rabbit IgG(HϩL), horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG(HϩL) and AP-conjugated goat anti-human IgG(HϩL) antibodies were purchased from Jackson ImmunoResearch Laboratories (Mississauga, Ontario, Canada). The soluble CEACAM1-Fc fusion protein was prepared as described previously (23) . The CEACAM-specific phycoerythrin (PE) conjugate (CD66-PE; clone B1.1) was obtained from Becton Dickinson. MicorTest 96 tissue culture plates were obtained from Becton Dickinson Labware (New Jersey, USA).
Bacterial strains and growth conditions. LPCIs of N. gonorrhoeae were cultured from urethral and endocervical swabs in a sexually transmitted disease clinic or as part of a longitudinal study of 302 commercial sex workers in the lower-socioeconomic-class district of Pumwani in Nairobi, Kenya, from July 1991 to December 1995 (48) . All male patients were symptomatic at the time of culture isolation. The swabs were streaked onto Thayer-Martin medium and incubated at 37°C and 5% CO 2 for 48 h before further characterization. N. gonorrhoeae was identified by colony morphology, oxidase test, and Gram stain reaction. Specimens were subcultured once after multiple colonies were picked, resuspended in skim milk containing 10% glycerol, and frozen at Ϫ70°C. Colony phenotypes were routinely monitored using a binocular microscope. Each colony phenotype representing more than 5% of the colonies from these primary stocks was selected for analysis. The isogenic N. gonorrhoeae MS11-derived strains N302 (Opa Ϫ ), N303 (Opa 50 , which binds heparan sulfate proteoglycan [HSPG]-specific receptors), N309 (Opa 52 , which binds CEACAM1, -3, -5, and -6), N311 (Opa 54 , which binds CEACAM1 and -5), and N313 (Opa 57 , which binds CEACAM1, -3, -5, and -6), and N496 (Opa Ϫ pilus ϩ ) were described previously (9, 20) and were generously provided by T. F. Meyer (Max-Planck-Institut für Infektionsbiologie, Berlin, Germany). Apart from strain N496, these derivatives of N. gonorrhoeae strain MS11 are pilus deficient and contain a chromosomal deletion of the opaC30 locus encoding the only Opa protein variant that mediates HSPG-dependent host cellular invasion by the strain (9) . Due to the phase-variable expression of pilus and Opa proteins, the gonococcal strains were cultured from frozen stock onto GC agar 2 days prior to experimentation, and colonies with the desired Opa and pilus phenotypes were visually identified with a binocular microscope and then subcultured to provide bacteria for experimentation on the subsequent day. Opa expression of gonococcal isolates used for infection experiments was confirmed by immunoblot analyses of total bacterial lysates using monoclonal antibody 4B12/C11, which recognizes all the Opa protein variants described (49) , and pilus expression was monitored using 10H5.1.1 antibody, which recognizes the conserved SM1 epitope (50) .
Cell lines. All cell lines were grown in RPMI 1640 containing L-glutamine and 5% fetal bovine serum (FBS) (Invitrogen) in a 37°C humidified incubator with 5% CO 2 . Lec11 cells, a CHO cell derivative (51), were used for expression of CEACAM receptors. CEACAM1 (52), CEACAM3 (53), CEACAM5, CEACAM6, CEACAM8 (54) , and the expression vector alone were transfected into Lec11 cells with Lipofectamine according to the manufacturer's protocol. The transfected cell lines were maintained in medium containing 400 g/ml G418-sulfate (CEACAM1, -5, -6, and -8 and vector alone) or 200 g/ml hygromycin B (CEACAM3). Ten million CEACAM-transfected cells were stained with the carcinoembryonic antigen (CEA) antibody (Dako, Denmark), which binds CEACAM1, CEACAM3, CEACAM5, and CEACAM6 (20) , followed by Bodipy FLconjugated goat anti-rabbit IgG(HϩL) (Molecular Probes) for fluorescence-activated cell sorting using a FACSCalibur flow cytometer (BD Biosciences, Mississauga, Ontario, Canada) in order to remove the cells that did not express CEACAMs.
CEACAM receptor expression. Flow cytometric analyses were carried out in order to confirm the surface localization of CEACAM receptors in Lec11 cells. Briefly, approximately 1 million trypsinized cells were incubated with 0.2 ml of phosphate-buffered saline (PBS) containing 1 mM MgCl 2 , 0.5 mM CaCl 2 , 0.22-m filtered (PBS-Mg-Ca), with 3% FBS (PBS-Mg-Ca-FBS) and 10 g/ml anti-CEA (Dako) for 1 h on ice. Unbound antibody was removed by washing the cell pellet with 3 changes of PBS-Mg-Ca-FBS. The cell pellets were then incubated with 0.2 ml of PBSMg-Ca-FBS containing 4 g/ml Bodipy FL-conjugated goat-anti-rabbit IgG(HϩL), and unbound antibody was removed as described above. The stained cells were fixed with PBS containing 1% PFA, and fluorescence was measured with a FACSCalibur. In 96-well binding assays, Lec11 monolayers were mock infected with serum-free RPMI medium containing 200 g/ml heparin and 0.2% BSA (RPMI-B-H) alone and stained with anti-CEA (Dako), followed by AP-conjugated goat anti-rabbit IgG. Substrate development was carried out as described for bacterial binding.
Ninety-six-well binding assay. The gonococcal isolates were divided into groups for experimentation in order to ease processing. For each binding experiment, the MS11 gonococcal strains, with a defined Opa phenotype, were included as experimental controls. Each gonococcal strain was tested in triplicate wells, and the experiment was repeated to ensure reproducibility.
Ninety-six-well plates were coated with PBS-Mg-Ca containing 0.2% gelatin (0.22-m filtered) for 30 min at 37°C prior to being seeded with Lec11 cells at 80% confluence. The next morning, the serum present in the growth medium was removed by washing with PBS-Mg-Ca 3 times. The cells were then incubated with RPMI-B-H at 37°C and 5% CO 2 until infection with bacteria, with the soluble heparin maintained throughout infection to prevent HSPG-dependent bacterial binding to the mammalian cells (20) . The gonococci were washed with PBS-Mg-Ca to remove outer membrane blebs and then resuspended in RPMI-B-H for density measurements. The bacterial suspensions were applied to each cell line at a multiplicity of infection (MOI) of 50. To synchronize infection, bacteria were centrifuged onto the monolayers at 67 ϫ g using a tabletop centrifuge at room temperature for 5 min. Infection was carried out at 37°C and 5% CO 2 for 2 h, at which point nonadherent bacteria were removed by washing the wells 3 times with PBS-Mg-Ca. The monolayers were then fixed with PBS-Mg-Ca containing 1% PFA. To detect the presence of bound gonococci, PFA was first removed by 3 washes with PBS, and the monolayers were permeabilized with PBS containing 0.4% Triton X-100 for 10 min, followed by 3 washes with PBS. PBS containing 0.2% BSA was used to block the wells for 15 min prior to the addition of antibody UTR01 at 1:800 dilution for 1 h. Unbound antibodies were removed by 3 washes with PBS, followed by the addition of AP-conjugated goat anti-rabbit IgG at 1:10,000 for 1 h and a final 3 washes with PBS. pNPP was used to reveal bound bacteria. Absorbance at 405 nm was recorded 3 and 20 h postpNPP addition using a Titertek Multiskan Plus plate reader. All staining steps were carried out at room temperature (RT).
Whole-cell dot blot. Gonococcal cells were washed once with PBSMg-Ca. Half a million cells in a 3-l volume were applied to a nitrocellulose membrane and air dried. The membrane was incubated in PBS containing 0.05% Tween 20 (PBS-T) and 5% skim milk powder overnight at 4°C. The next morning, the membrane was incubated with 0.5 g/ml of CEACAM1-Fc in blocker for 2 h at room temperature. The membrane was extensively washed prior to incubation with AP-conjugated goat antihuman IgG antibody at a 1:5,000 dilution. Excess antibody was removed by repeated washing in PBS-T. The alkaline phosphatase reaction was carried out by preequilibrating the membrane in 0.1 M Tris, pH 9.5, and subsequently incubating it in a solution containing 0.1 M Tris, pH 9.5, 7 mM MgCl 2 , 135 M BCIP, and 122 M NBT.
Statistical analysis.
The bacterial strains were tested in groups with MS11 strains as controls. In order to present and compare all the data, binding data from the various plates were normalized to the MS11 controls. Data from two MS11 strains that fall within the dynamic range of the substrate reaction were chosen for the transformation of binding data from individual experiments. Briefly, the averages for the two MS11 control strains were first normalized to their respective cumulative means. A normalization factor for each experiment was calculated by taking the average of the two normalized MS11 averages. The data from each experiment are presented as the average among the triplicate wells, subtracting the averages from the no-GC control wells, and transformed according to the normalization factor. The standard deviation was calculated from the triplicate wells and adjusted with the same normalization factor.
Primary neutrophil isolation. Human neutrophils were isolated from citrated whole blood taken from healthy volunteers by venipuncture using Ficoll-Paque Plus (Amersham Biosciences, Buckinghamshire, England). Contaminating erythrocytes were removed by dextran sedimentation and hypotonic shock, as described previously (41) .
Bacterial infections for immunofluorescence microscopy. PMNs (5 ϫ 10 5 ) were centrifuged onto coverslips at 514 ϫ g for 10 min. Cells were infected at an MOI of 10 (for binding and internalization studies) in a volume of 500 l, recentrifuged for 5 min at 57 ϫ g to facilitate bacterial association with the cells, and then incubated at 37°C for the indicated durations. Postinfection, samples were washed with Hanks balanced salt solution (HBSS) and fixed using 3.7% paraformaldehyde. The cells were stained for CEACAM and bacteria and observed as described previously (18) . Intracellular bacteria were differentiated from extracellular bacteria via exclusion of N. gonorrhoeae-specific antibody, as described previously (41) .
Oxidative-burst and degranulation assays. For the chemiluminescence-based oxidative-burst assay, 5 ϫ 10 5 cells were incubated with 25 g/ml 5-amino-2,3-dihydro-1,4-phthalazinedione (luminol) (Sigma) in a volume of 100 l and then treated with agonists in a total volume of 200 l, with each sample done in triplicate. Infections proceeded for 60 min at 37°C, after which luminescence was read using a Tecan plate reader with i-control software. For the flow cytometry-based degranulation assay (CEACAM surface expression), 10 6 PMNs were treated with agonists in 500 l of HBSS for 30 min at 37°C. The infections were stopped by centrifugation at 2,400 ϫ g for 3 min at RT. The cell pellets were fixed in 1% PFA and stained with 1.25 g of PE-conjugated rat anti-mouse CEACAM in a total volume of 200 l. Elastase and lactoferrin release assays were performed essentially as described previously (55) . Briefly, 10 6 PMNs were exposed to agonists in a total volume of 500 l and then incubated for 1 h at 37°C. The cells were then pelleted, and the supernatants were collected. For the elastase assay, 50 l of supernatant was diluted 2-fold in PBS, incubated with 100 l DQ elastin substrate conjugated to Bodipy FL (from the EnzCheck Elastase kit; Molecular Probes), and then incubated for 2 h at RT before reading the fluorescence with excitation at 488 nm and emission at 515 nm. For the elastase assays, the percent release is shown, 57 , and Opa Ϫ pilus ϩ ) and low-passage-number strains 4034 and 4058. 4034A to -D and 4058A to -C variants were derived from original isolates (OI) based on distinct colony morphology. The immunoblot results for all the isolates are summarized in Table 1. calculated as the amount of the protein in the supernatant divided by the amount released after phorbol myristate acetate (PMA) treatment. Lactoferrin release from PMN granules was assayed by enzyme-linked immunosorbent assay (ELISA), as described previously (56) . For CEACAM release, 10 6 PMNs were infected for 1 h and fixed in 1% PFA. The cells were stained with CEACAM-PE, and fluorescence was measured with a FACSCalibur.
Cytokine measurements. Cells (5 ϫ 10 5 ) were infected with N. gonorrhoeae at an MOI of 10 and incubated at 37°C for 3 h. The infections were then stopped by centrifugation at 2,400 ϫ g for 5 min at 4°C, and the supernatants were collected. Quantitative measurements of cytokines (interleukin 8 and tumor necrosis factor [TNF]) were performed using ELISA kits from BD Biosciences.
RESULTS
Most low-passage-number clinical isolates display Opa protein expression. Since the receptor specificity of Opa variants cannot 2176A  2096  2  2176B  2097  2  2177  2063  1  2177A  2098  5  2177B  2099  1  2178  2064  2  Ͼ4  2178A  2100  3  Ͼ4  2178B  2101  2  Ͼ4  2179  2065  1  2179A  2102  0  1  2179B  2103  0  2180  2066  2  2180A  2104  3  2180B  2105  0  2180C  2106  2   Cervix  4001  2067  1  4001A  2107  2  4002  2068  2  4002A  2108  1  4002B  2109  2  4004  2069  1  4004A  2110  1  4004B  2111  1  4004C  2112  2  4005  2070  1  4005A  2113  1  1  4005B  2114  1  4005C  2115  1  4007  2071  1  1  4007A  2116  1  1  4007B  2117  1  4007C  2118  1  4014  2072  1  4014A  2119  1  4014B  2120  1  4014C  2121  1  4015  2073  1  4015A  2112  1  4015B  2123  2  4026  2074  2  4026A 2124 2 1 be predicted from their protein sequences, we set out to assess the CEACAM-binding phenotype of isolates minimally passaged from clinical specimens. We obtained stocks passaged twice (once from the specimen and once for freezing) from clinical samples taken from the male urethra or female endocervix. The 28 isolates selected represent the predominant gonococcal serovars circulating in Nairobi during the study period (48) . Western blot analysis using 4B12/C11 antibody, which cross-reacts with all known N. gonorrhoeae Opa variants, revealed that 96% of the isolates (27 out of 28 strains) expressed at least one Opa protein ( Fig. 1 and Table  1 ). This is consistent with previous reports indicating that gonococcal strains isolated from natural infections express Opa proteins (12) (13) (14) . We detected pilus in only 8 of 28 strains (29%) ( Fig.  1 and Table 1 ). Since piliation is generally considered to be present in fresh clinical isolates, it is possible that strain piliation may have been lost by pilE recombination and/or pilC phase variation during in vitro subculture (57) . Microscopic examination of the LPCIs grown on GC agar revealed that each contained multiple distinct colony morphologies. Since gonococcal colony phenotypes often reveal changes in Opa and/or pilus expression, we considered each colony type separately. Sixty-four morphologically distinct gonococcal isolates were derived from the original 28 specimens, and each was then tested for Opa and pilus expression. Since phase variation is an ongoing process, subculturing was performed using a bottom-lit binocular dissecting microscope to confirm selection of colonies reflecting the originally observed phenotype and to exclude any visually apparent phase variants arising during passage. Western blot analyses showed that 64% (14 out of 22) of male-derived isolates expressed detectable Opa variants, while 83% (35 out of 42) of female-derived strains displayed one or more Opa variants (Table 1) . Thus, while 96% of people in the cohort had Opaexpressing gonococci and the majority of colonies obtained from most specimens were Opa ϩ (Table 1) , the infections often (6 of 18 female infections and 4 of 10 in males) also contained Opa Ϫ N. gonorrhoeae. While most isolates displayed a single Opa and/or pilus variant band on the immunoblots, it is pertinent to note that some of the isolates expressed more than one discernible Opa protein and/or pilin variant (Table 1) . Indeed, since variants with similar electrophoretic mobilities would not be discriminated, it is possible that this occurs more frequently than is apparent.
Establishing a high-throughput CEACAM-binding assay. We hypothesized that the high prevalence of Opa expression in our LPCIs suggests that Opa proteins facilitate infection. However, since each Opa variant may have a different spectrum of CEACAM binding, since the spectrum of binding has the potential to drastically affect the host cellular response to infection (28, 30, 32, 38, 43, 44, 47) , and since the pattern of CEACAM expression varies between sexes and cell types, we sought to characterize the binding specificity of each N. gonorrhoeae isolate.
For this purpose, we transfected the Chinese hamster ovaryderived Lec11 cell line with individual CEACAM receptors (CEACAM1, CEACAM3, CEACAM5, CEACAM6, and CEACAM8). Since N. gonorrhoeae adhesins, such as pilus, have strict specificity for human receptors, this rodent cell line was chosen to eliminate any binding with endogenously expressed cellular receptors. Expression and maintenance of human CEACAM receptors on the cell surface was confirmed by in situ staining ( Fig. 2A ) and flow cytometry (Fig. 2B) .
In order to verify that the CEACAM receptors expressed on Lec11 cells maintain their Opa binding specificity and to validate our multiplexed approach, we tested the binding of well-defined Opa variants expressed by recombinant N. gonorrhoeae MS11 strains to these cell lines in a 96-well format binding assay. Since gonococci can express adhesins that bind HSPG receptors, including certain individual Opa variants (18, 58, 59) , soluble heparin was maintained within the culture medium to block HSPG (but not CEACAM) binding (18) . The CEACAM-binding pattern observed for each strain tended to correlate with what was previously reported (20) (Fig. 2C) . Wells that were mock infected (no GC) and gonococci that do not express Opa (Opa Ϫ ) allowed us to establish background signals for N. gonorrhoeae and/or antibody binding to the Lec11 cell lines. Opa 52 -expressing gonococci bound CEACAM1-, CEACAM3-, CEACAM5-, and CEACAM6-expressing cells. While Opa 57 is generally considered to also bind all four bacteria were removed by washing, the monolayers were fixed and permeabilized, and bound gonococci were detected using UTR01 antibody, followed by the goat anti-rabbit AP-conjugated secondary antibody. Averages of the absorbances at 405 nm from triplicate wells after developing with colorimetric reagent, with the standard deviations, are presented. of these CEACAMs, its binding to CEACAM3 was modest in this assay system. As expected, Opa 54 -expressing gonococci bound only CEACAM1-and CEACAM5-expressing cells. Gonococci that express pili but not Opa (Opa Ϫ pilus ϩ ) did not bind Lec11 cells but instead showed evidence of binding to wells without Lec11 cells ("gelatin" and "medium" wells). Opa 50 -expressing gonococci showed preference for Lec11 CEACAM1 cells and none of the other cell lines. Although Opa 50 interacts specifically with HSPG receptors (18, 60) , it does display a low level of CEACAM1 binding (20) . Since Opa 50 binds the carbohydrate component of HSPGs, the difference in binding could plausibly be attributed to distinct CEACAM1 glycosylation patterns between the Lec11 cell lines and those previously used; however, detailed analysis of CEACAM glycosylation in these cells versus other cells has not been performed.
LPCIs show distinct CEACAM-binding patterns. Next, we used the high-throughput binding assay to determine the CEACAM-binding phenotypes of the gonococcal strains recovered from low-passage-number clinical samples (Fig. 3) . Eightytwo of 92 isolates (89%) bind to one or more CEACAMs. While most of them bind to both CEACAM1 and CEACAM5, 10 strains are specific for CEACAM1 (2173B, 2174A, 2177A, 2177B, 2179A,  4002B, Opa   57   2171  2172  2173  2174  2175  2176  2177  2178  2179  2180  A  B  C  A  B  C  A  B  C  C  A  A  A  A  A  A  B  B  B  B  B  B  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  4002  4001  4004  4005  4007  4014  4015  4026  4029  4033  4034  4039  4058  4077  4102  4121  4174 (27%) bound CEACAM3, and the level of binding to CEACAM3-expressing cells tended to be considerably less than that to the other CEACAMs (Fig. 3) , suggesting that there was selection against Opa variants that bind this neutrophil-restricted receptor. Among the original 28 LPCIs, CEACAM6 binding was more common in strains isolated from female (67%) than male (50%) infections (Fig. 4B) . More strikingly, CEACAM5 binding was evident for all (100%) male isolates but for only 67% of femalederived specimens (Fig. 4B ). This suggests a stronger selection for CEACAM5-specific Opa variants in men versus women, though the relatively small sample size (10 male versus 18 female samples) makes it inappropriate to draw a definitive conclusion from this relationship.
Finally, it is pertinent to note that, while none of the recombinant Opa variants tested to date are able to bind to CEACAM8 (16, 18, 19) , several isolates showed very low-level binding to CEACAM8-expressing cells (Fig. 3) , whereas none bound to the untransfected Lec11 cell line (data not shown). Given that CEACAMs are heavily glycosylated, it is plausible that this interaction is distinct from the protein-protein-mediated binding between Opa and the other receptors (53) . However, since each of these isolates also bound to other human CEACAMs, it also seems feasible that certain variants have very low affinity for this closely related receptor.
To validate the results of the Lec11-based infection assay, we used an established whole-cell blotting assay using soluble CEACAM1-Fc fusion protein (23) to reassess the CEACAM1-binding specificity of the commonly used MS11 strains versus the LPCIs. As expected, recombinant MS11 strains expressing Opa 57 N. gonorrhoeae showed binding to CEACAM1-Fc, while Opa Ϫ N. gonorrhoeae did not (Fig. 4A) . The vast majority of the original (mixed-phenotype) LPCIs (91% of the isolates) also bound to CEACAM1-Fc, corroborating the results from the 96-well assay (Fig. 4B) , although certain variants displayed clearer binding to either the soluble (2174 and 4001) or cell-expressed (4005) CEACAM1.
Overall, these results suggest that there is a selective advantage for expressing Opa variants that bind CEACAM1 and CEACAM5 in vivo, presumably because they are expressed by mucosal epithelia. In contrast, the low level of binding to CEACAM3, which is a neutrophil-expressed phagocytic receptor, indicates that it may be detrimental to the bacteria.
CEACAM binding affects human neutrophil responses to LPCIs. Characterization of individual CEACAM function in neutrophilic cell lines showed that Opa-mediated neutrophil activation is mediated by CEACAM3 signaling, while CEACAM1 and CEACAM6 allowed bacterial internalization without triggering production of reactive oxygen species (ROS) or release of toxic granule proteins (44) . However, all of the studies focusing on neutrophil responses to Opa-CEACAM binding have been done exclusively with the commonly studied N. gonorrhoeae strains MS11 (44, 45, 47, 61, 62) and FA1090 (63, 64) .
The presence of naturally occurring gonococcal phase variants that either do or do not express Opa proteins, obtained from a single low-passage-number clinical specimen, allowed us to establish whether the CEACAM-binding specificity of primary LPCIs elicited cellular responses reminiscent of those seen with the recombinant strains. Isolate 4034B expresses Opa (here referred to as the Opa ϩ isolate) ( Fig. 1) and shows binding to CEACAM1, CEACAM3, CEACAM5, and CEACAM6 (Fig. 3) , while 4034C lacks Opa expression (here referred to as the Opa Ϫ isolate) ( Fig. 1 ) and does not bind CEACAM receptors (Fig. 3) . When we assessed association of these two bacterial variants with human PMNs, the Opa ϩ isolate was bound and internalized to a greater extent than the Opa Ϫ isolate (Fig. 5A and B) . Moreover, the Opa ϩ isolate was killed faster than the Opa Ϫ strain (Fig. 5C ). Next, we assessed the activation of neutrophil antimicrobial responses after infection with the two phenotypic variants. The Opa ϩ variant activated production of higher levels of ROS than did the variant that lacks CEACAM-binding capacity ( Fig. 6A and  B) . The Opa ϩ variant also drives a robust degranulation of both primary and secondary granules, evident from the release of primary (elastase) and secondary (lactoferrin) granule contents, while infection with the Opa Ϫ variant did not lead to increased release of any granule proteins over uninfected controls (Fig. 6C) . While CEACAMs are normally expressed on the surfaces of neu- trophils, they also comprise a major component of neutrophil secondary granules. Consequently, the Opa-dependent neutrophil degranulation also increased the expression of CEACAMs on the neutrophil surface (Fig. 6D ), whereas infection with the Opa Ϫ strain did not.
We recently revealed that CEACAM3 engagement activates a proinflammatory transcriptional program in neutrophils, which results in production of proinflammatory cytokines via a signaling pathway that is independent of bacterial phagocytosis (47) . Consistent with this, infection with the Opa ϩ phase variant led to significantly higher levels of both TNF and IL-8 (Fig. 6E) . Considered together, these results indicate that the CEACAM-binding phenotype of primary LPCIs confers cell association and cellular response outcomes reflecting those seen with commonly used recombinant strains and consistent with the expression of Opa variants that bind to CEACAM3 on neutrophils being detrimental to the gonococci.
DISCUSSION
N. gonorrhoeae is highly adapted to life in humans. Its narrow host range is largely defined by its adhesin proteins and immune evasion mechanisms, which are specific for human cellular receptors and serum proteins (59) . Pilus facilitates initial bacterial attachment to the urogenital mucosa (4), where other adhesins can then confer a tighter secondary binding to epithelium-expressed receptors (3, 18, 58, 59) . Of these, the Opa proteins mediate tight adherence and transcytosis to the subepithelial space (25, 26) . The phase variability of the genes encoding Opa proteins and pilus allows N. gonorrhoeae to change the patterns of expression of these adhesins randomly. Consequently, during a natural infection there may exist a mixed population of bacteria varying in piliated phenotypes and/or the numbers and types of Opa variants expressed. This ongoing diversification of phenotypes is balanced by ongoing phenotypic selection of variants expressing adhesins or other factors that facilitate infection within an individual and/or within a particular tissue-specific niche. In vitro cell culture and primary cell-based systems have clearly established that most Opa variants can bind one or more human CEACAMs, and transgenic mouse-based studies corroborate the importance of this binding for the establishment of infection (37, 38) . Experimental human urethral model studies also suggest the importance of Opa proteins and pilus (6, (12) (13) (14) (65) (66) (67) , yet the binding specificity of Opa variants expressed during human infection had not been addressed before this study.
The frequent phase-variable switching on and off of pilus and Opa expression necessitated that isolates be minimally passaged before phenotypic studies. To achieve this, we obtained primary LPCIs collected as part of a longitudinal study of commercial sex workers and STD clinic patients in Nairobi, Kenya. The analysis of pilus and Opa expression showed that the majority of the isolates expressed one or more Opa variants. All 11 chromosomally located opa alleles are constitutively transcribed regardless of whether their respective translated proteins are phase varied on or off (68) . Moreover, due to the hypervariable nature of the surfaceexposed loops of each Opa variant, their binding specificities can- not be inferred from the protein sequences. Since a bioinformatics-based approach was not feasible, and since the presence or absence of binding function is more important than the specific Opa alleles that confer binding, we sought to characterize the CEACAM-binding phenotype of each isolate. To this end, we developed a high-throughput binding assay that allows quantitative assessment of CEACAM-binding specificity. This revealed that most isolates bound both CEACAM1 and CEACAM5, perhaps reflecting the need for transmission between niches expressing these two receptors. However, when considered more closely, it is noteworthy that all the isolates from men bound CEACAM5 whereas only two-thirds of the isolates from women did so. Interestingly, in this regard, squamous cells of the lower genital tract tend to express CEACAM5 whereas columnar epithelial cells of the female endocervical and upper genital tract instead express CEACAM1 (27) . While CEACAM family expression within the male urethra has not been mapped, the difference in receptor specificities of the recovered isolates makes it enticing to consider whether there is selection for CEACAM5 binding at this site.
In contrast to the selection for CEACAM1 and CEACAM5 binding, we observed an apparent selection against binding to the neutrophil CEACAM3 receptor, with only 27% of all isolates showing measurable binding to CEACAM3. Moreover, for those isolates that did bind to CEACAM3, the detected signal strength was generally weaker than to the other CEACAMs. This difference in binding cannot be explained by lower levels of CEACAM3 expression by the transfected cell line, as all CEACAMs were expressed on the surface at similar levels. Instead, the selection against CEACAM3 binding is consistent with binding to the receptor having detrimental consequences for the bacteria. Consistent with this, we observed that, in contrast to the Opa Ϫ variant, Opa ϩ phase variants that bound human neutrophils were more effectively engulfed and elicited a greater oxidative-burst, degranulation, and inflammatory-cytokine expression response.
Curiously, several isolates were able to bind to one or more CEACAMs while seemingly lacking Opa expression. Whether this stems from their expression of Opa variants that are not recognized by the available Opa-specific monoclonal antibodies and/or from CEACAM binding occurring in an Opa-independent manner, as has recently been reported for N. meningitidis (69) , will require further study of the isolates. Nevertheless, CEACAM binding defines the phenotype of these strains, regardless of any such antigenic differences.
This study highlights the exquisite interplay of host-pathogen interactions that allows N. gonorrhoeae to persist in a human population. The ongoing phase variability of 11 Opa proteins allows their randomized expression, yet human infection selects for bacterial variants that specifically bind CEACAM1 and CEACAM5, but not CEACAM3. The selective pressure required to drive a preference between the human CEACAMs despite the high sequence and structural similarity of their respective bacterium binding N domains (42, 70) is a testament to the ongoing evolutionary dance between humans and our intimately associated neisserial partners.
